As Zika cases fade, researchers look for clues on how the virus is transmitted, especially in pregnant women

August 11, 2017 by Catherine Cray, Pittsburgh Post-Gazette
Transmission electron microscope image of negative-stained, Fortaleza-strain Zika virus (red), isolated from a microcephaly case in Brazil. The virus is associated with cellular membranes in the center. Credit: NIAID

Whatever happened to the Zika virus?

The virus, mostly spread by mosquitoes, triggered alarming headlines in 2015-16 as cases climbed throughout South America, the Caribbean and South Florida - leaving hundreds of newborns with severe in its wake. The National Institutes of Health called it a pandemic.

But when mosquito season returned in 2017, Zika had largely fizzled.

In addition to dramatic drops in pan-American countries, the number of reported symptomatic cases in the U.S. plummeted from 5,102 in 2016 to 185 in 2017.

A British study last summer predicted the virus would burn itself out - meaning enough people would develop antibodies against Zika to stem its spread - in three years. It hasn't disappeared, but reported cases this year are far down.

Despite the trend, concern remains, especially for pregnant women, said Kristen Mertz, a medical epidemiologist at the Allegheny County Health Department. Infected women are 20 times more likely to have children with deformities than women without Zika, according to a CDC report.

The fact that the virus infected fetuses signaled to Carolyn Coyne, a University of Pittsburgh researcher who studies immunology, that "something is different about Zika."

To harm the fetus, the Zika virus must cross the placental barrier that separates the mother and the fetus. Most viruses are unable to do that, she said, and scientists still don't know how it happens.

A study published this week in the PNAS journal by Pitt and UPMC researchers shows advancements in understanding how Zika crosses this barrier.

But first the team had to create a new lab model of the placenta.

"Lab models of the human placenta have always been lacking," said Coyne, an associate professor in the Department of Pediatrics at UPMC who co-authored the study. She said that this is because the placenta is a very complicated organ.

Earlier work primarily used flat cell line models that didn't account for the movement of blood and other shear forces that occur in the human body, particularly in the placenta.

"In the human body, our cells are not static," said Coyne, who holds a Ph.D. in pharmacology and completed her post-doctoral study in microbiology. "Cells in the lab respond very differently when you expose them to these shear forces."

Using the new model, researchers studied Zika infection during the second trimester, an earlier stage of pregnancy than they'd looked at before, when infection would more likely cause fetal disease.

Earlier stages of pregnancy are more important to study because the risks of infection are greater then, Coyne said. This could be because the fetuses are more vulnerable, or because the placental barrier is weaker, she said.

In 2016, according to a CDC report, 10 percent of women in the U.S. with a confirmed Zika infection had a baby with a birth defect. For women who were infected during their first trimester, 15 percent had children with birth defects.

Previous studies by Pitt researchers demonstrated that, in later stages of pregnancy, cells on the placental barrier continuously release type III interferon, an immune cell that helps to prevent infection by Zika. The research team wondered: did that happen earlier in pregnancy? If not, the absence of that type of immune cell could be a weakness in the placental barrier that allowed Zika virus to infect the fetus, Coyne said.

The study found that during the second trimester, the placenta does continuously release type III interferon, which rules out the hypothesis.

Coyne said that her team's work is to create a road map of how Zika crosses the placental barrier. This finding rules out one route, but "there must be other roads," and the lab model of the placenta that Coyne and her colleagues developed will be vital in studying them.

Mertz said that her greatest concern is possible future risks to infants with mothers infected by Zika: "We still don't know the long-term impacts."

She said that she doesn't know whether Zika is coming back again, and she doesn't have a complete explanation for the sudden drop in infection, but immunity plays a role.

After an individual is infected with Zika, they develop lifelong immunity - meaning that they cannot become infected or transmit the disease again, Mertz said. In areas with high rates of infection, this means that there are fewer individuals susceptible to the .

Coyne said that the importance of the PNAS study goes beyond Zika, because it reveals new information about how the placental barrier works.

Going forward, she has new questions on her mind: If type III interferons are being continuously released throughout pregnancy, what impact does this have on the mother? And how do these findings apply to other viruses that cross the placental barrier?

Explore further: Scientists track Zika virus transmission in mice

Related Stories

Scientists track Zika virus transmission in mice

August 3, 2017
National Institutes of Health (NIH) scientists have developed a mouse model to study Zika virus transmitted sexually from males to females, as well as vertically from a pregnant female to her fetus. They are using the model ...

Research provides clues to how Zika virus breaches the placental barrier

September 15, 2016
New research reveals that in pregnant women, Zika virus infection damages certain cells that affect placental formation and function. Furthermore, herpes simplex virus-2 (HSV-2) infection augments placental sensitivity to ...

Zika vaccine protects fetus against infection and birth defects

July 13, 2017
Immunizing female mice with a Zika vaccine can protect their developing fetus from infection and birth defects during pregnancy, according to new research from The University of Texas Medical Branch at Galveston. The findings ...

Study identifies how Zika virus infects the placenta

August 18, 2016
In a new study, Yale researchers demonstrate Zika virus infection of cells derived from human placentas. The research provides insight into how Zika virus may be transmitted from expectant mother to fetus, resulting in infection ...

Malaria drug protects fetuses from Zika infection

July 10, 2017
Devastating consequences of Zika virus infection are suffered in the womb, where the virus can cause brain damage and sometimes death.

Zika birth defects in 5 percent of infected women in US islands

June 8, 2017
Five percent of women in the US territories who were infected with the Zika virus while pregnant had fetus or babies with defects, including microcephaly, government health data said Thursday.

Recommended for you

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.